Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster.

Favresse, Julien; Dogné, Jean-Michel; Douxfils, Jonathan

Favresse, Julien; Dogné, Jean-Michel; Douxfils, Jonathan.

Afiliación

Favresse J; Department of Laboratory Medicine, Clinique Saint-Luc Bouge, Namur, Bouge, Belgium.
Dogné JM; Department of Pharmacy, University of Namur, Namur Research Institute for Life Sciences, Namur, Belgium.
Douxfils J; Department of Pharmacy, University of Namur, Namur Research Institute for Life Sciences, Namur, Belgium.

Clin Chem Lab Med ; 60(7): e153-e156, 2022 06 27.

Article en En | MEDLINE | ID: mdl-35452575

Asunto(s)

Vacuna BNT162; COVID-19; Anticuerpos Antivirales; Personal de Salud; Humanos; SARS-CoV-2

Palabras clave

COVID-19; Omicron; SARS-CoV-2; breakthrough; humoral response; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article